Show simple item record

dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorMok, T
dc.contributor.authorNishio, M
dc.contributor.authorKim, D
dc.contributor.authorWilner, K
dc.contributor.authorReisman, A
dc.contributor.authorIyer, S
dc.contributor.authorSolomon, B
dc.date.accessioned2016-04-22T14:55:09Zen
dc.date.available2016-04-22T14:55:09Zen
dc.date.issued2015en
dc.identifier.citationQuality of Life for Crizotinib vs. Chemotherapy in Asian ALK-Positive NSCLC Patients. 2015, 10(9):S378-S379 JTOen
dc.identifier.urihttp://hdl.handle.net/10541/606634en
dc.language.isoenen
dc.titleQuality of life for crizotinib vs chemotherapy in Asian ALK-positive NSCLC patientsen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentManchester University and the Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalJournal of Thoracic Oncologyen


This item appears in the following Collection(s)

Show simple item record